Clarke, D., Smith, D. Managing starting material stability to maximize manufacturing flexibility and downstream efficiency. Cell & Gene Therapy Insights 2019; 5(2), 303-314. doi: 10.18609/cgti.2019.033
Menu
Clarke, D., Smith, D. Managing starting material stability to maximize manufacturing flexibility and downstream efficiency. Cell & Gene Therapy Insights 2019; 5(2), 303-314. doi: 10.18609/cgti.2019.033
This website uses cookies to ensure you get the best experience on our website.
